Theranostic Contact Lens for Ocular Cystinosis Utilizing Gold Nanoparticles

Ocular cystinosis is a disease in which accumulated cystine crystals cause damage to the eyes, necessitating timely treatment and ongoing monitoring of cystine levels. The current treatment involves frequent administration of cysteamine eye drops, which suffer from low bioavailability and can lead t...

Full description

Saved in:
Bibliographic Details
Main Authors: Eunbe Ha, Hwajeong Kang, Hyeran Noh
Format: Article
Language:English
Published: MDPI AG 2025-01-01
Series:Biosensors
Subjects:
Online Access:https://www.mdpi.com/2079-6374/15/1/16
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832588939164123136
author Eunbe Ha
Hwajeong Kang
Hyeran Noh
author_facet Eunbe Ha
Hwajeong Kang
Hyeran Noh
author_sort Eunbe Ha
collection DOAJ
description Ocular cystinosis is a disease in which accumulated cystine crystals cause damage to the eyes, necessitating timely treatment and ongoing monitoring of cystine levels. The current treatment involves frequent administration of cysteamine eye drops, which suffer from low bioavailability and can lead to drug toxicity, making it essential to prescribe an appropriate dosage based on the patient’s condition. Additionally, cystine crystal levels are typically assessed subjectively via slit-lamp examination, requiring frequent clinical visits and causing discomfort for the patient. In this study, we propose a theranostic contact lens that simultaneously performs therapy and diagnosis on a single platform utilizing gold nanoparticles (GNPs). The binding interactions between GNPs and cystine were confirmed in solution, and thermodynamic analysis further elucidated the bonding force between the two substances. With a comprehensive understanding of these interactions, we investigated the potential of the theranostic GNP-loaded contact lens (GNP-CL). Upon exposure to various concentrations of cystine, the GNP-CL demonstrated distinct color changes, transitioning from red to blue. This color shift enabled quantitative monitoring of cystine levels. The treatment efficacy was validated by confirming a reduction in cystine concentration following the reaction. This platform has the potential to improve disease management in ocular cystinosis by reducing the reliance on cysteamine and offering an objective self-monitoring tool that does not require specialized equipment.
format Article
id doaj-art-df1a8a6f0fdb4446bb3e27dd4d6f5963
institution Kabale University
issn 2079-6374
language English
publishDate 2025-01-01
publisher MDPI AG
record_format Article
series Biosensors
spelling doaj-art-df1a8a6f0fdb4446bb3e27dd4d6f59632025-01-24T13:25:26ZengMDPI AGBiosensors2079-63742025-01-011511610.3390/bios15010016Theranostic Contact Lens for Ocular Cystinosis Utilizing Gold NanoparticlesEunbe Ha0Hwajeong Kang1Hyeran Noh2Department of Optometry, Seoul National University of Science and Technology, 232 Gongneung-ro, Nowon-gu, Seoul 01811, Republic of KoreaDepartment of Optometry, Seoul National University of Science and Technology, 232 Gongneung-ro, Nowon-gu, Seoul 01811, Republic of KoreaDepartment of Optometry, Seoul National University of Science and Technology, 232 Gongneung-ro, Nowon-gu, Seoul 01811, Republic of KoreaOcular cystinosis is a disease in which accumulated cystine crystals cause damage to the eyes, necessitating timely treatment and ongoing monitoring of cystine levels. The current treatment involves frequent administration of cysteamine eye drops, which suffer from low bioavailability and can lead to drug toxicity, making it essential to prescribe an appropriate dosage based on the patient’s condition. Additionally, cystine crystal levels are typically assessed subjectively via slit-lamp examination, requiring frequent clinical visits and causing discomfort for the patient. In this study, we propose a theranostic contact lens that simultaneously performs therapy and diagnosis on a single platform utilizing gold nanoparticles (GNPs). The binding interactions between GNPs and cystine were confirmed in solution, and thermodynamic analysis further elucidated the bonding force between the two substances. With a comprehensive understanding of these interactions, we investigated the potential of the theranostic GNP-loaded contact lens (GNP-CL). Upon exposure to various concentrations of cystine, the GNP-CL demonstrated distinct color changes, transitioning from red to blue. This color shift enabled quantitative monitoring of cystine levels. The treatment efficacy was validated by confirming a reduction in cystine concentration following the reaction. This platform has the potential to improve disease management in ocular cystinosis by reducing the reliance on cysteamine and offering an objective self-monitoring tool that does not require specialized equipment.https://www.mdpi.com/2079-6374/15/1/16ocular cystinosisgold nanoparticlestheranosticbiosensorcontact lens
spellingShingle Eunbe Ha
Hwajeong Kang
Hyeran Noh
Theranostic Contact Lens for Ocular Cystinosis Utilizing Gold Nanoparticles
Biosensors
ocular cystinosis
gold nanoparticles
theranostic
biosensor
contact lens
title Theranostic Contact Lens for Ocular Cystinosis Utilizing Gold Nanoparticles
title_full Theranostic Contact Lens for Ocular Cystinosis Utilizing Gold Nanoparticles
title_fullStr Theranostic Contact Lens for Ocular Cystinosis Utilizing Gold Nanoparticles
title_full_unstemmed Theranostic Contact Lens for Ocular Cystinosis Utilizing Gold Nanoparticles
title_short Theranostic Contact Lens for Ocular Cystinosis Utilizing Gold Nanoparticles
title_sort theranostic contact lens for ocular cystinosis utilizing gold nanoparticles
topic ocular cystinosis
gold nanoparticles
theranostic
biosensor
contact lens
url https://www.mdpi.com/2079-6374/15/1/16
work_keys_str_mv AT eunbeha theranosticcontactlensforocularcystinosisutilizinggoldnanoparticles
AT hwajeongkang theranosticcontactlensforocularcystinosisutilizinggoldnanoparticles
AT hyerannoh theranosticcontactlensforocularcystinosisutilizinggoldnanoparticles